Cargando…
Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues
PROTACs represent an emerging field in medicinal chemistry, which has already led to the development of compounds that reached clinical studies. Posttranslational modifications contribute to the complexity of proteomes, with 2846 disease-associated sites. PROTAC field is very advanced in targeting k...
Autores principales: | Pichlak, Marta, Sobierajski, Tomasz, Błażewska, Katarzyna M., Gendaszewska-Darmach, Edyta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10481767/ https://www.ncbi.nlm.nih.gov/pubmed/37667522 http://dx.doi.org/10.1080/14756366.2023.2254012 |
Ejemplares similares
-
Targeting Small
GTPases and Their Prenylation in Diabetes
Mellitus
por: Gendaszewska-Darmach, Edyta, et al.
Publicado: (2021) -
Protein Prenyltransferases and Their Inhibitors: Structural and Functional Characterization
por: Marchwicka, Aleksandra, et al.
Publicado: (2022) -
Synthesis of the 6-Substituted Imidazo[1,2-a]Pyridine-3-yl-2- Phosphonopropionic Acids as Potential Inhibitors of Rab Geranylgeranyl Transferase
por: Kusy, Damian, et al.
Publicado: (2021) -
Rational design, optimization, and biological evaluation of novel α-Phosphonopropionic acids as covalent inhibitors of Rab geranylgeranyl transferase
por: Małolepsza, Joanna, et al.
Publicado: (2022) -
Nucleotide receptors as targets in the pharmacological enhancement of dermal wound healing
por: Gendaszewska-Darmach, Edyta, et al.
Publicado: (2011)